Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Humana warns high medical costs may hit 2024 forecast, shares slump

Published 01/18/2024, 06:52 AM
Updated 01/18/2024, 11:50 AM
© Reuters. FILE PHOTO: A screen displays the logo and trading information for Humana on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., December 6, 2023.  REUTERS/Brendan McDermid/File Photo

By Sriparna Roy

(Reuters) -U.S. health insurer Humana (NYSE:HUM) said on Thursday an increase in demand for medical care among older adults would hurt fourth-quarter results and added uncertainty to its 2024 outlook, sending its shares down 14%.

Higher demand would drive up medical costs in the fourth quarter, Humana said, becoming the second major insurer to flag a jump in such expenses in less than a week. Larger rival UnitedHealth (NYSE:UNH) on Friday reported higher-than-expected medical service costs but said it did not expect those levels to remain through 2024.

Shares of UnitedHealth, CVS and Elevance Health fell between 2% and 5%, after Humana signaled higher costs could be an industry-wide issue.

Health insurers recorded higher medical costs in 2023 due to a rise in demand for procedures such as orthopedic and heart-related surgeries.

Demand for medical care rose during November and December among people enrolled in Medicare Advantage plans for those aged 65 and older, Humana said. Along with higher-than-expected demand for inpatient services, patients were also opting for more outpatient surgeries.

Analysts at J.P.Morgan and Leerink said the higher use of medical services also raised the possibility that the company would not meet its 2025 earnings targets.

Humana will now report fourth-quarter results on Jan. 25, a week before previously expected, where it will provide an update on the full-year forecast.

"Longer-term investors may be questioning the growth prospects of the Medicare Advantage market, too," said Morningstar analyst Julie Utterback.

Humana said it experienced lower-than-expected growth in new members during Medicare's annual enrollment period.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

According to Utterback, the weak results during the annual enrollment period could also be adding to investor concerns.

Humana said it expects to account for the high costs in the 2025 Medicare Advantage pricing cycle.

The company expects adjusted medical benefit ratio in its insurance segment at 91.4% in the fourth quarter, versus 89.5% forecast previously. The medical benefit ratio refers to the percentage of premiums spent by an insurer on medical care.

Latest comments

야발 ㅋㅋㅋㅋ
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.